Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis, Necrotizing | 6 | 2018 | 82 | 2.060 |
Why?
|
| Docosahexaenoic Acids | 4 | 2021 | 35 | 1.810 |
Why?
|
| Arachidonic Acid | 3 | 2021 | 65 | 1.270 |
Why?
|
| Dietary Supplements | 3 | 2021 | 133 | 1.240 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2023 | 53 | 1.010 |
Why?
|
| Infant, Premature | 8 | 2021 | 308 | 0.990 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2023 | 15 | 0.890 |
Why?
|
| Probiotics | 3 | 2017 | 92 | 0.800 |
Why?
|
| Fish Oils | 2 | 2023 | 15 | 0.790 |
Why?
|
| Infant, Newborn | 11 | 2023 | 2614 | 0.760 |
Why?
|
| Milk, Human | 4 | 2017 | 51 | 0.760 |
Why?
|
| Hypertriglyceridemia | 1 | 2023 | 72 | 0.760 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 105 | 0.650 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 22 | 0.580 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2016 | 26 | 0.580 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2017 | 118 | 0.480 |
Why?
|
| Phospholipids | 1 | 2016 | 113 | 0.480 |
Why?
|
| Platelet Activating Factor | 2 | 2013 | 53 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 349 | 0.450 |
Why?
|
| Infant, Premature, Diseases | 2 | 2013 | 85 | 0.440 |
Why?
|
| Eating | 1 | 2014 | 165 | 0.400 |
Why?
|
| Inflammation | 2 | 2018 | 1068 | 0.400 |
Why?
|
| Infant | 4 | 2023 | 3363 | 0.320 |
Why?
|
| Prospective Studies | 4 | 2021 | 4671 | 0.230 |
Why?
|
| Infant, Extremely Premature | 1 | 2023 | 43 | 0.190 |
Why?
|
| Triglycerides | 1 | 2023 | 236 | 0.190 |
Why?
|
| Humans | 12 | 2023 | 96093 | 0.160 |
Why?
|
| Biomarkers | 2 | 2017 | 1932 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2008 | 3581 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1791 | 0.130 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2016 | 19 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 77 | 0.120 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 71 | 0.120 |
Why?
|
| Birth Weight | 1 | 2016 | 152 | 0.120 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Erythrocytes | 1 | 2016 | 254 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1715 | 0.110 |
Why?
|
| Neuraminidase | 1 | 2013 | 47 | 0.100 |
Why?
|
| Time Factors | 3 | 2016 | 5585 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2016 | 9173 | 0.090 |
Why?
|
| Microbiota | 1 | 2017 | 426 | 0.090 |
Why?
|
| Female | 5 | 2021 | 50030 | 0.080 |
Why?
|
| Male | 4 | 2021 | 45870 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 935 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 101 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 713 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 872 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2015 | 469 | 0.040 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 36 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 53 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 89 | 0.030 |
Why?
|
| Term Birth | 1 | 2013 | 9 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1034 | 0.020 |
Why?
|
| Lactation | 1 | 2013 | 55 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 358 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 296 | 0.020 |
Why?
|
| Premature Birth | 1 | 2013 | 130 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2533 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 825 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 12538 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1320 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 3107 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 28914 | 0.010 |
Why?
|